A new startup is targeting a classic orthopedic issue: taking a proven, non-invasive technology (bone growth stimulation) that had gone essentially un-redesigned for two decades and modernizing it around patient compliance, digital connectivity, and sleek form factors.
There isn’t a good orthopedics solution for every patient—particularly when the critical challenge isn't the metal hardware, but the months-long race to solid bony fusion after spine surgery.
Spinal fusion remains an unforgiving contest between biological healing and mechanical fatigue. Non-invasive bone growth stimulators (BGS) utilizing capacitive-coupling electrical fields have carried robust Level-I clinical evidence for decades, demonstrating an approximate 31% increase in fusion success rates and more than doubling the odds of overall clinical success. Yet the delivery mechanism stood virtually frozen in time for twenty years: heavy, rigid contraptions that fight daily movement, zero objective compliance verification, and an opaque post-op recovery window. Because osteogenesis is fundamentally dose-dependent, real-world under-use quietly sabotaged patient outcomes while leaving surgeons in the dark.
The Problem...
